Vanberra Signal
Free trial

ConsoneAI

Curated by Signal

Provider of an artificial intelligence driven solutions for drug development process

Health Technologyconsoneai.com

Overview

Provider of an artificial intelligence driven solutions for drug development process. The product designed to aid drug development by predicting patient outcomes from preclinical to clinical stages. The platform leverages a toxicity database containing chemical compounds, employing deep learning techniques tailored to individual compounds based on the chemical similarities.

Key facts

Founded
2020
Headquarters
Wetherby, United Kingdom
Stage
Sign up to view
Industry
Health Technology

Business model

1 product or service
Sign up to view

Contact

Email
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • Galexxy Corporation

    Provider of hemp-based wellness products to improve health

    Health TechnologyLondon, United Kingdom

  • Mobistudy

    Provider of an online platform for clinical trial recruitment

    Health TechnologyUnited Kingdom

  • YU

    Provider of an application to record emotions

    Health TechnologyEdinburgh, United Kingdom

About ConsoneAI

What does ConsoneAI do?

Provider of an artificial intelligence driven solutions for drug development process.

Where is ConsoneAI headquartered?

ConsoneAI is headquartered in Wetherby, United Kingdom.

When was ConsoneAI founded?

ConsoneAI was founded in 2020.

Which sector is ConsoneAI in?

ConsoneAI operates in Health Technology.

Who are ConsoneAI's competitors?

Companies similar to ConsoneAI include Galexxy Corporation, Mobistudy, and YU.